Blencowe H, Cousens S, Oestergaard MZ, Chou D, Moller AB, Narwal R, Adler A, Vera Garcia C, Rohde S, Say L, Lawn JE. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. Lancet. 2012;379:2162–72.
Article
PubMed
Google Scholar
Natarajan G, Shankaran S. Short- and long-term outcomes of moderate and late preterm infants. Am J Perinatol. 2016;33:305–17.
Article
PubMed
Google Scholar
Kotecha SJ, Dunstan FD, Kotecha S. Long term respiratory outcomes of late preterm-born infants. Semin Fetal Neonatal Med. 2012;17:77–81.
Article
PubMed
Google Scholar
Kair LR, Leonard DT, Anderson JM. Bronchopulmonary dysplasia. Pediatr Rev. 2012;33:255–6.
Article
PubMed
Google Scholar
Bhandari A, Bhandari V. Pitfalls, problems, and progress in bronchopulmonary dysplasia. Pediatrics. 2009;123:1562–73.
Article
PubMed
Google Scholar
Northway WH Jr, Rosan RC, Porter DY. Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. N Engl J Med. 1967;276:357–68.
Article
PubMed
Google Scholar
Abman SH, Bancalari E, Jobe A. The evolution of bronchopulmonary dysplasia after 50 years. Am J Respir Crit Care Med. 2017;195:421–4.
Article
PubMed
Google Scholar
Baraldi E, Filippone M. Chronic lung disease after premature birth. N Engl J Med. 2007;357:1946–55.
Article
CAS
PubMed
Google Scholar
Amata E, Pittalà V, Arena E, Marrazzo A, Parenti C, Prezzavento O, Nabavi SM, Salerno L. Role of the Nrf2/HO-1 axis in bronchopulmonary dysplasia and hyperoxic lung injuries. Clin Sci. 2017;131:1701–12.
Article
CAS
PubMed
Google Scholar
Dennery PA. Heme oxygenase in neonatal lung injury and repair. Antioxid Redox Signal. 2014;21:1881–92.
Article
CAS
PubMed
PubMed Central
Google Scholar
Jobe AH. Mechanisms of lung injury and bronchopulmonary dysplasia. Am J Perinatol. 2016;33:1076–8.
Article
PubMed
Google Scholar
Aslam M, Baveja R, Liang OD, Fernandez-Gonzalez A, Lee C, Mitsialis SA, Kourembanas S. Bone marrow stromal cells attenuate lung injury in a murine model of neonatal chronic lung disease. Am J Respir Crit Care Med. 2009;180:1122–30.
Article
CAS
PubMed
PubMed Central
Google Scholar
Auten RL, Mason SN, Auten KM, Brahmajothi M. Hyperoxia impairs postnatal alveolar epithelial development via NADPH oxidase in newborn mice. Am J Physiol Lung Cell Mol Physiol. 2009;297:L134–42.
Article
CAS
PubMed
PubMed Central
Google Scholar
Balasubramaniam V, Mervis CF, Maxey AM, Markham NE, Abman SH. Hyperoxia reduces bone marrow, circulating, and lung endothelial progenitor cells in the developing lung: implications for the pathogenesis of bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol. 2007;292:L1073–84.
Article
CAS
PubMed
Google Scholar
Tanswell AK, Freeman BA. Pulmonary antioxidant enzyme maturation in the fetal and neonatal rat. I. Developmental profiles. Pediatr Res. 1984;18:584–7.
Article
CAS
PubMed
Google Scholar
Kobr J, Kuntscher V, Molacek J, Hes O, Pizingerova K, Kocova J, Topolcan O. Diffuse alveolar damage due to inappropriate strategy of mechanical ventilation in an experimental porcine model. In Vivo. 2010;24:699–704.
CAS
PubMed
Google Scholar
Coalson JJ. Pathology of new bronchopulmonary dysplasia. Semin Neonatol. 2003;8:73–81.
Article
PubMed
Google Scholar
Morrow LA, Wagner BD, Ingram DA, Poindexter BB, Schibler K, Cotten CM, Dagle J, Sontag MK, Mourani PM, Abman SH. Antenatal determinants of bronchopulmonary dysplasia and late respiratory disease in preterm infants. Am J Respir Crit Care Med. 2017. https://doi.org/10.1164/rccm.201612-2414oc (Epub Mar 1).
PubMed
Google Scholar
Lapcharoensap W, Kan P, Powers RJ, Shaw GM, Stevenson DK, Gould JB, Wirtschafter DD, Lee HC. The relationship of nosocomial infection reduction to changes in neonatal intensive care unit rates of bronchopulmonary dysplasia. J Pediatr. 2017;180:105–9.
Article
PubMed
Google Scholar
Ballard AR, Mallett LH, Pruszynski JE, Cantey JB. Chorioamnionitis and subsequent bronchopulmonary dysplasia in very-low-birth weight infants: a 25-year cohort. J Perinatol. 2016;36:1045–8.
Article
CAS
PubMed
Google Scholar
Hartling L, Liang Y, Lacaze-Masmonteil T. Chorioamnionitis as a risk factor for bronchopulmonary dysplasia: a systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed. 2012;97:F8–17.
Article
PubMed
Google Scholar
Metcalfe A, Lisonkova S, Sabr Y, Stritzke A, Joseph KS. Neonatal respiratory morbidity following exposure to chorioamnionitis. BMC Pediatr. 2017;17:128.
Article
PubMed
PubMed Central
Google Scholar
Eriksson L, Haglund B, Odlind V, Altman M, Ewald U, Kieler H. Perinatal conditions related to growth restriction and inflammation are associated with an increased risk of bronchopulmonary dysplasia. Acta Paediatr. 2015;104:259–63.
Article
CAS
PubMed
Google Scholar
Poindexter BB, Martin CR. Impact of nutrition on bronchopulmonary dysplasia. Clin Perinatol. 2015;42:797–806.
Article
PubMed
Google Scholar
Bhandari V, Bizzarro MJ, Shetty A, Zhong X, Page GP, Zhang H, Ment LR, Gruen JR, Neonatal Genetics Study Group. Familial and genetic susceptibility to major neonatal morbidities in preterm twins. Pediatrics. 2006;117:1901–6.
Article
PubMed
Google Scholar
Hadchouel A, Durrmeyer X, Bouzigon E, Incitti R, Huusko J, Jarreau PH, Lenclen R, Demenais F, Franco-Montoya ML, Layouni I, Patkai J, Bourbon J, Hallman M, Danan C, Delacourt C. Identification of SPOCK2 as a susceptibility gene for bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2011;184:1164–70.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wang H, St Julien KR, Stevenson DK, Hoffmann TJ, Witte JS, Lazzeroni LC, Krasnow MA, Quaintance CC, Oehlert JW, Jelliffe-Pawlowski LL, Gould JB, Shaw GM, O’Brodovich HM. A genome-wide association study (GWAS) for bronchopulmonary dysplasia. Pediatrics. 2013;132:290–7.
Article
PubMed
PubMed Central
Google Scholar
Kwinta P, Pietrzyk JJ. Preterm birth and respiratory disease in later life. Expert Rev Respir Med. 2010;4:593–604.
Article
PubMed
Google Scholar
Klinger G, Sokolover N, Boyko V, Sirota L, Lerner-Geva L, Reichman B. Perinatal risk factors for bronchopulmonary dysplasia in a national cohort of very-low-birthweightinfants. Am J Obstet Gynecol. 2013;208:115.e1–9.
Article
PubMed
Google Scholar
Patel RM. Short- and long-term outcomes for extremely preterm infants. Am J Perinatol. 2016;33:318–28.
Article
PubMed
PubMed Central
Google Scholar
Howling SJ, Northway WH Jr, Hansell DM, Moss RB, Ward S, Müller NL. Pulmonary sequelae of bronchopulmonary dysplasia survivors: high-resolution CT findings. AJR Am J Roentgenol. 2000;174:1323–6.
Article
CAS
PubMed
Google Scholar
Shennan AT, Dunn MS, Ohlsson A, Lennox K, Hoskins EM. Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in the neonatal period. Pediatrics. 1988;82:527–32.
CAS
PubMed
Google Scholar
Ryan RM. A new look at bronchopulmonary dysplasia classification. J Perinatol. 2006;26:207–9.
Article
PubMed
Google Scholar
Day CL, Ryan RM. Bronchopulmonary dysplasia: new becomes old again! Pediatr Res. 2017;81:210–3.
PubMed
Google Scholar
Maniscalco WM, Watkins RH, D’Angio CT, Ryan RM. Hyperoxic injury decreases alveolar epithelial cell expression of vascular endothelial growth factor (VEGF) in neonatal rabbit lung. Am J Respir Cell Mol Biol. 1997;16:557–67.
Article
CAS
PubMed
Google Scholar
Bhandari V, Choo-Wing R, Lee CG, Zhu Z, Nedrelow JH, Chupp GL, Zhang X, Matthay MA, Ware LB, Homer RJ, Lee PJ, Geick A, de Fougerolles AR, Elias JA. Hyperoxia causes angiopoietin 2-mediated acute lung injury and necrotic cell death. Nat Med. 2006;12:1286–93.
Article
CAS
PubMed
PubMed Central
Google Scholar
Thomas W, Seidenspinner S, Kramer BW, Wirbelauer J, Kawczyńska-Leda N, Szymankiewicz M, Speer CP. Airway angiopoietin-2 in ventilated very preterm infants: association with prenatal factors and neonatal outcome. Pediatr Pulmonol. 2011;46:777–84.
Article
PubMed
Google Scholar
De Paepe ME, Patel C, Tsai A, Gundavarapu S, Mao Q. Endoglin (CD105) up-regulation in pulmonary microvasculature of ventilated preterm infants. Am J Respir Crit Care Med. 2008;178:180–7.
Article
PubMed
PubMed Central
CAS
Google Scholar
Harijith A, Choo-Wing R, Cataltepe S, Yasumatsu R, Aghai ZH, Janér J, Andersson S, Homer RJ, Bhandari V. A role for matrix metalloproteinase 9 in IFNγ-mediated injury in developing lungs: relevance to bronchopulmonary dysplasia. Am J Respir Cell Mol Biol. 2011;44:621–30.
Article
CAS
PubMed
PubMed Central
Google Scholar
Van Marter LJ. Epidemiology of bronchopulmonary dysplasia. Semin Fetal Neonatal Med. 2009;14:358–66.
Article
PubMed
Google Scholar
Gortner L, Misselwitz B, Milligan D, Zeitlin J, Kollee L, Boerch K, Agostino R, Van Reempts P, Chabernaud JL, Bréart G, Papiernik E, Jarreau PH, Carrapato M, Gadzinowski J, Draper E, Members of the MOSAIC Research Group. Rates of bronchopulmonary dysplasia in very preterm neonates in Europe: results from the MOSAIC cohort. Neonatology. 2011;99:112–7.
Article
PubMed
Google Scholar
Aukland SM, Rosendahl K, Owens CM, Fosse KR, Eide GE, Halvorsen T. Neonatal bronchopulmonary dysplasia predicts abnormal pulmonary HRCT scans in long-term survivors of extreme preterm birth. Thorax. 2009;64:405–10.
Article
CAS
PubMed
Google Scholar
Wong PM, Lees AN, Louw J, Lee FY, French N, Gain K, Murray CP, Wilson A, Chambers DC. Emphysema in young adult survivors of moderate-to-severe bronchopulmonary dysplasia. Eur Respir J. 2008;32:321–8.
Article
CAS
PubMed
Google Scholar
Aquino SL, Schechter MS, Chiles C, Ablin DS, Chipps B, Webb WR. High-resolution inspiratory and expiratory CT in older children and adults with bronchopulmonary dysplasia. Am J Roentgenol. 1999;173:963–7.
Article
CAS
Google Scholar
Oppenheim C, Mamou-Mani T, Sayegh N, de Blic J, Scheinmann P, Lallemand D. Bronchopulmonary dysplasia: value of CT in identifying pulmonary sequelae. Am J Roentgenol. 1994;163:169–72.
Article
CAS
Google Scholar
Mahut B, De Blic J, Emond S, Benoist MR, Jarreau PH, Lacaze-Masmonteil T, et al. Chest computed tomography findings in bronchopulmonary dysplasia and correlation with lung function. Arch Dis Child Fetal Neonatal Ed. 2007;92:F459–64.
Article
PubMed
PubMed Central
Google Scholar
Hakulinen AL, Heinonen K, Länsimies E, Kiekara O. Pulmonary function and respiratory morbidity in school-age children born prematurely and ventilated for neonatal respiratory insufficiency. Pediatr Pulmonol. 1990;8:226–32.
Article
CAS
PubMed
Google Scholar
Northway WH Jr, Moss RB, Carlisle KB, Parker BR, Popp RL, Pitlick PT, Eichler I, Lamm RL, Brown BW Jr. Late pulmonary sequelae of bronchopulmonary dysplasia. N Engl J Med. 1990;323:1793–9.
Article
PubMed
Google Scholar
Islam JY, Keller RL, Aschner JL, Hartert TV, Moore PE. Understanding the short- and long-term respiratory outcomes of prematurity and bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2015;192:134–56.
Article
PubMed
PubMed Central
Google Scholar
Baraldi E, Filippone M, Trevisanuto D, Zanardo V, Zacchello F. Pulmonary function until two years of life in infants with bronchopulmonary dysplasia. Am J Respir Crit Care Med. 1997;155:149–55.
Article
CAS
PubMed
Google Scholar
Robin B, Kim YJ, Huth J, Klocksieben J, Torres M, Tepper RS, Castile RG, Solway J, Hershenson MB, Goldstein-Filbrun A. Pulmonary function in bronchopulmonary dysplasia. Pediatr Pulmonol. 2004;37:236–42.
Article
PubMed
Google Scholar
Fakhoury KF, Sellers C, Smith EO, Rama JA, Fan LL. Serial measurements of lung function in a cohort of young children with bronchopulmonary dysplasia. Pediatrics. 2010;125:e1441–7.
Article
PubMed
Google Scholar
Kotecha SJ, Edwards MO, Watkins WJ, Henderson AJ, Paranjothy S, Dunstan FD, Kotecha S. Effect of preterm birth on later FEV1: a systematic review and meta-analysis. Thorax. 2013;68:760–6.
Article
PubMed
Google Scholar
Hacking DF, Gibson AM, Robertson C, Doyle LW. Respiratory function at age 8–9 after extremely low birthweight or preterm birth in Victoria in 1997. Pediatr Pulmonol. 2013;48:449–55.
Article
PubMed
Google Scholar
Lamarche-Vadel A, Blondel B, Truffer P, Burguet A, Cambonie G, Selton D, Arnaud C, Lardennois C, du Mazaubrun C, N’Guyen S, Mathis J, Bréart G, Kaminski M, EPIPAGE Study Group. Re-hospitalization in infants younger than 29 weeks’ gestation in the EPIPAGE cohort. Acta Paediatr. 2004;93:1340–5.
Article
CAS
PubMed
Google Scholar
Ralser E, Mueller W, Haberland C, Fink FM, Gutenberger KH, Strobl R, Kiechl-Kohlendorfer U. Rehospitalization in the first 2 years of life in children born preterm. Acta Paediatr. 2012;101:e1–5.
Article
PubMed
Google Scholar
Greenough A, Alexander J, Burgess S, Chetcuti PA, Cox S, Lenney W, Turnbull F, Shaw NJ, Woods A, Boorman J, Coles S, Turner J. Home oxygen status and rehospitalisation and primary care requirements of infants with chronic lung disease. Arch Dis Child. 2002;86:40–3.
Article
CAS
PubMed
PubMed Central
Google Scholar
Garcia-Garcia ML, Gonzalez-Carrasco E, Quevedo S, Munoz C, Sanchez-Escudero V, Pozo F, Casas I, Calvo C. Clinical and virologic characteristics of early and moderate preterm infants readmitted with viral respiratory infections. Pediatr Infect Dis J. 2015;34:693–9.
Article
PubMed
Google Scholar
Groothuis JR, Gutierrez KM, Lauer BA. Respiratory syncytial virus infection in children with bronchopulmonary dysplasia. Pediatrics. 1988;82:199–203.
CAS
PubMed
Google Scholar
El Mazloum D, Moschino L, Bozzetto S, Baraldi E. Chronic lung disease of prematurity: long-term respiratory outcome. Neonatology. 2014;105:352–6.
Article
PubMed
CAS
Google Scholar
Baraldi E, Bonetto G, Zacchello F, Filippone M. Low exhaled nitric oxide in school-age children with bronchopulmonary dysplasia and airflow limitation. Am J Respir Crit Care Med. 2005;171:68–72.
Article
PubMed
Google Scholar
Halvorsen T, Skadberg BT, Eide GE, Røksund O, Aksnes L, Øymar K. Characteristics of asthma and airway hyper-responsiveness after premature birth. Pediatr Allergy Immunol. 2005;16:487–94.
Article
PubMed
Google Scholar
Qu Y, Cao Y, Liao M, Lu Z. Sagittal-lung CT measurements in the evaluation of asthma-COPD overlap syndrome: a distinctive phenotype from COPD alone. Radiol Med. 2017. https://doi.org/10.1007/s11547-017-0743-9 (Epub Mar 3).
PubMed
Google Scholar
Karila C, Saulnier JP, Elie C, Taupin P, Scheinmann P, Le Bourgeois M, Waernessycle S, de Blic J. Exercise alveolar hypoventilation in long-term survivors of bronchopulmonary dysplasia. Rev Mal Respir. 2008;25:303–12.
Article
CAS
PubMed
Google Scholar
An HS, Bae EJ, Kim GB, Kwon BS, Beak JS, Kim EK, et al. Pulmonary hypertension in preterm infants with bronchopulmonary dysplasia. Korean Circ J. 2010;40:131–6.
Article
PubMed
PubMed Central
Google Scholar
Al-Ghanem G, Shah P, Thomas S, Banfield L, El Helou S, Fusch C, Mukerji A. Bronchopulmonary dysplasia and pulmonary hypertension: a meta-analysis. J Perinatol. 2017;37:414–9.
Article
CAS
PubMed
Google Scholar
Mourani PM, Sontag MK, Younoszai A, Ivy DD, Abman SH. Clinical utility of echocardiography for the diagnosis and management of pulmonary vascular disease in young children with chronic lung disease. Pediatrics. 2008;121:317–25.
Article
PubMed
PubMed Central
Google Scholar
Kumar VHS. Diagnostic approach to pulmonary hypertension in premature neonates. Children. 2017;4.
Aikio O, Metsola J, Vuolteenaho R, Perhomaa M, Hallman M. Transient defect in nitric oxide generation after rupture of fetal membranes and responsiveness to inhaled nitric oxide in very preterm infants with hypoxic respiratory failure. J Pediatr. 2012;161:397–403.
Article
CAS
PubMed
Google Scholar
Newnham JP, Dickinson JE, Hart RJ, Pennell CE, Arrese CA, Keelan JA. Strategies to prevent preterm birth. Front Immunol. 2014;5:584.
Article
PubMed
PubMed Central
Google Scholar
Roberts D, Brown J, Medley N, Dalziel SR. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev. 2017;3:CD004454.
PubMed
Google Scholar
Thome UH, Ambalavanan N. Permissive hypercapnia to decrease lung injury in ventilated preterm neonates. Semin Fetal Neonatal Med. 2009;14:21–7.
Article
PubMed
Google Scholar
Thome UH, Genzel-Boroviczeny O, Bohnhorst B, Schmid M, Fuchs H, Rohde O, Avenarius S, Topf HG, Zimmermann A, Faas D, Timme K, Kleinlein B, Buxmann H, Schenk W, Segerer H, Teig N, Bläser A, Hentschel R, Heckmann M, Schlösser R, Peters J, Rossi R, Rascher W, Böttger R, Seidenberg J, Hansen G, Zernickel M, Bode H, Dreyhaupt J, Muche R, Hummler HD, PHELBI Study Group. Neurodevelopmental outcomes of extremely low birthweight infants randomised to different PCO2 targets: the PHELBI follow-up study. Arch Dis Child Fetal Neonatal Ed. 2017. https://doi.org/10.1136/archdischild-2016-311581 (Epub Jan 13).
PubMed
Google Scholar
Fischer HS, Bührer C. Avoiding endotracheal ventilation to prevent bronchopulmonary dysplasia: a meta-analysis. Pediatrics. 2013;132:e1351–60.
Article
PubMed
Google Scholar
Kugelman A, Feferkorn I, Riskin A, Chistyakov I, Kaufman B, Bader D. Nasal intermittent mandatory ventilation versus nasal continuous positive airway pressure for respiratory distress syndrome: a randomized, controlled, prospective study. J Pediatr. 2007;150:521–6.
Article
PubMed
Google Scholar
Lemyre B, Laughon M, Bose C, Davis PG. Early nasal intermittent positive pressure ventilation (NIPPV) versus early nasal continuous positive airway pressure (NCPAP) for preterm infants. Cochrane Database Syst Rev. 2016;12:CD005384.
PubMed
Google Scholar
Lemyre B, Davis PG, De Paoli AG, Kirpalani H. Nasal intermittent positive pressure ventilation (NIPPV) versus nasal continuous positive airway pressure (NCPAP) for preterm neonates after extubation. Cochrane Database Syst Rev. 2017;2:CD003212.
PubMed
Google Scholar
Stenson BJ. Oxygen saturation targets for extremely preterm infants after the NeOProM trials. Neonatology. 2016;109:352–8.
Article
PubMed
Google Scholar
Nelin LD, Bhandari V. How to decrease bronchopulmonary dysplasia in your neonatal intensive care unit today and “tomorrow”. F1000Res. 2017;6:539.
Article
PubMed
PubMed Central
Google Scholar
Oh W, Poindexter BB, Perritt R, Lemons JA, Bauer CR, Ehrenkranz RA, Toll BJ, Poole K, Wright LL, Neonatal Research Network. Association between fluid intake and weight loss during the first ten days of life and risk of bronchopulmonary dysplasia in extremely low birth weight infants. J Pediatr. 2005;147:786–90.
Article
PubMed
Google Scholar
Hartnoll G, Bétrémieux P, Modi N. Randomised controlled trial of postnatal sodium supplementation on oxygen dependency and body weight in 25–30 week gestational age infants. Arch Dis Child Fetal Neonatal Ed. 2000;82:F19–23.
Article
CAS
PubMed
PubMed Central
Google Scholar
Stewart A, Brion LP. Intravenous or enteral loop diuretics for preterm infants with (or developing) chronic lung disease. Cochrane Database Syst Rev. 2011;9:CD001453.
Google Scholar
Biniwale MA, Ehrenkranz RA. The role of nutrition in the prevention and management of bronchopulmonary dysplasia. Semin Perinatol. 2006;30:200–8.
Article
PubMed
Google Scholar
Stevens TP, Harrington EW, Blennow M, Soll RF. Early surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome. Cochrane Database Syst Rev. 2007;4:CD003063.
Google Scholar
Rigo V, Lefebvre C, Broux I. Surfactant instillation in spontaneously breathing preterm infants: a systematic review and meta-analysis. Eur J Pediatr. 2016;175:1933–42.
Article
PubMed
Google Scholar
Curstedt T, Calkovska A, Johansson J. New generation synthetic surfactants. Neonatology. 2013;103:327–30.
Article
CAS
PubMed
Google Scholar
Halliday HL, Ehrenkranz RA, Doyle LW. Early (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants. Cochrane Database Syst Rev. 2009;1:CD001146.
Google Scholar
Doyle LW, Ehrenkranz RA, Halliday HL. Late (> 7 days) postnatal corticosteroids for chronic lung disease in preterm infants. Cochrane Database Syst Rev. 2014;5:CD001145.
Google Scholar
Doyle LW, Halliday HL, Ehrenkranz RA, Davis PG, Sinclair JC. An update on the impact of postnatal systemic corticosteroids on mortality and cerebral palsy in preterm infants: effect modification by risk of bronchopulmonary dysplasia. J Pediatr. 2014;165:1258–60.
Article
CAS
PubMed
Google Scholar
Baud O, Maury L, Lebail F, Ramful D, El Moussawi F, Nicaise C, Zupan-Simunek V, Coursol A, Beuchée A, Bolot P, Andrini P, Mohamed D, Alberti C, PREMILOC Trial Study Group. Effect of early low-dose hydrocortisone on survival without bronchopulmonary dysplasia in extremely preterm infants (PREMILOC): a double-blind, placebo-controlled, multicentre, randomised trial. Lancet. 2016;387:1827–36.
Article
CAS
PubMed
Google Scholar
Baud O, Trousson C, Biran V, Leroy E, Mohamed D, Alberti C, PREMILOC Trial Group. Association between early low-dose hydrocortisone therapy in extremely preterm neonates and neurodevelopmental outcomes at 2 years of age. JAMA. 2017;317:1329–37.
Article
CAS
PubMed
Google Scholar
Jefferies AL. Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants. Paediatr Child Health. 2012;17:573–4.
Article
PubMed
PubMed Central
Google Scholar
National Perinatal epidemiology Unit. Minidex trial. https://www.npeu.ox.ac.uk/minidex. Accessed 5 June 2017.
Shinwell ES, Portnov I, Meerpohl JJ, Karen T, Bassler D. Inhaled corticosteroids for bronchopulmonary dysplasia: a meta-analysis. Pediatrics. 2016;138.
Bassler D, Plavka R, Shinwell ES, Hallman M, Jarreau PH, Carnielli V, Van den Anker JN, Meisner C, Engel C, Schwab M, Halliday HL, Poets CF, NEUROSIS Trial Group. Early inhaled budesonide for the prevention of bronchopulmonary dysplasia. N Engl J Med. 2015;373:1497–506.
Article
CAS
PubMed
Google Scholar
Schmidt B, Roberts RS, Davis P, Doyle LW, Barrington KJ, Ohlsson A, Solimano A, Tin W, Caffeine for Apnea of Prematurity Trial Group. Caffeine therapy for apnea of prematurity. N Engl J Med. 2006;354:2112–21.
Article
CAS
PubMed
Google Scholar
Schmidt B, Roberts RS, Davis P, Doyle LW, Barrington KJ, Ohlsson A, Solimano A, Tin W, Caffeine for Apnea of Prematurity Trial Group. Long term effects of caffeine therapy for apnea of prematurity. N Engl J Med. 2007;357:1893–902.
Article
CAS
PubMed
Google Scholar
Dobson NR, Patel RM, Smith PB, Kuehn DR, Clark J, Vyas-Read S, Herring A, Laughon MM, Carlton D, Hunt CE. Trends in caffeine use and association between clinical outcomes and timing of therapy in very low birth weight infants. J Pediatr. 2014;164:992–8.
Article
CAS
PubMed
PubMed Central
Google Scholar
Taha D, Kirkby S, Nawab U, Dysart KC, Genen L, Greenspan JS, Aghai ZH. Early caffeine therapy for prevention of bronchopulmonary dysplasia in preterm infants. J Matern Fetal Neonatal Med. 2014;27:1698–702.
Article
CAS
PubMed
Google Scholar
Lodha A, Seshia M, McMillan DD, Barrington K, Yang J, Lee SK, Shah PS, Canadian Neonatal Network. Association of early caffeine administration and neonatal outcomes in very preterm neonates. JAMA Pediatr. 2015;169:33–8.
Article
PubMed
Google Scholar
Weichelt U, Cay R, Schmitz T, Strauss E, Sifringer M, Bührer C, Endesfelder S. Prevention of hyperoxia-mediated pulmonary inflammation in neonatal rats by caffeine. Eur Respir J. 2013;41:966–73.
Article
CAS
PubMed
Google Scholar
Darlow BA, Graham PJ, Rojas-Reyes MX. Vitamin A supplementation to prevent mortality and short- and long-term morbidity in very low birth weight infants. Cochrane Database Syst Rev. 2016;8:CD000501.
Google Scholar
Wardle SP, Hughes A, Chen S, Shaw NJ. Randomised controlled trial of oral vitamin A supplementation in preterm infants to prevent chronic lung disease. Arch Dis Child Fetal Neonatal Ed. 2001;84:F9–13.
Article
CAS
PubMed
PubMed Central
Google Scholar
Uberos J, Miras-Baldo M, Jerez-Calero A, Narbona-López E. Effectiveness of vitamin A in the prevention of complications of prematurity. Pediatr Neonatol. 2014;55:358–62.
Article
CAS
PubMed
Google Scholar
The Neonatal Inhaled Nitric Oxide Study Group. Inhaled nitric oxide in full-term and nearly fullterm infants with hypoxic respiratory failure. N Engl J Med. 1997;336:597–604.
Article
Google Scholar
Barrington KJ, Finer N, Pennaforte T. Inhaled nitric oxide for respiratory failure in preterm infants. Cochrane Database Syst Rev. 2017;1:CD000509.
PubMed
Google Scholar
Cole FS, Alleyne C, Barks JD, Boyle RJ, Carroll JL, Dokken D, Edwards WH, Georgieff M, Gregory K, Johnston MV, Kramer M, Mitchell C, Neu J, Pursley DM, Robinson WM, Rowitch DH. Consensus development conference statement: inhaled nitric-oxide therapy for premature infants. Pediatrics. 2011;127:363–9.
Article
PubMed
Google Scholar
Sokol GM, Konduri GG, Van Meurs KP. Inhaled nitric oxide therapy for pulmonary disorders of the term and preterm infant. Semin Perinatol. 2016;40:356–69.
Article
PubMed
PubMed Central
Google Scholar
Gadhia MM, Cutter GR, Abman SH, Kinsella JP. Effects of early inhaled nitric oxide therapy and vitamin A supplementation on the risk for bronchopulmonary dysplasia in premature newborns with respiratory failure. J Pediatr. 2014;164:744–8.
Article
CAS
PubMed
Google Scholar
Möbius MA, Thébaud B. Bronchopulmonary dysplasia—where have all the stem cells gone? Origin and (potential) function of resident lung stem cells. Chest. 2017. https://doi.org/10.1016/j.chest.2017.04.173 (Epub May 4).
PubMed
Google Scholar
Sinclair K, Yerkovich ST, Chambers DC. Mesenchymal stem cells and the lung. Respirology. 2013;18:397–411.
Article
PubMed
Google Scholar
Lesage F, Jimenez J, Toelen J, Deprest J. Preclinical evaluation of cell-based strategies to prevent or treat bronchopulmonary dysplasia in animal models: a systematic review. J Matern Fetal Neonatal Med. 2017. https://doi.org/10.1080/14767058.2017.1301927 (Epub ahead of print), (Epub March 21).
PubMed
Google Scholar
Tian ZF, Du J, Wang B, Hong XY, Feng ZC. Intravenous infusion of rat bone marrow-derived mesenchymal stem cells ameliorates hyperoxia-induced lung injury in neonatal rats. Nan fang yi ke da xue xue bao. 2007;27:1692–5.
CAS
PubMed
Google Scholar
van Haaften T, Byrne R, Bonnet S, Rochefort GY, Akabutu J, Bouchentouf M, Rey-Parra GJ, Galipeau J, Haromy A, Eaton F, Chen M, Hashimoto K, Abley D, Korbutt G, Archer SL, Thébaud B. Airway delivery of mesenchymal stem cells prevents arrested alveolar growth in neonatal lung injury in rats. Am J Respir Crit Care Med. 2009;180:1131–42.
Article
PubMed
PubMed Central
CAS
Google Scholar
Makhlough A, Shekarchian S, Moghadasali R, Einollahi B, Hosseini SE, Jaroughi N, Bolurieh T, Baharvand H, Aghdami N. Safety and tolerability of autologous bone marrow mesenchymal stromal cells in ADPKD patients. Stem Cell Res Ther. 2017;8:116.
Article
PubMed
PubMed Central
Google Scholar
Stolk J, Broekman W, Mauad T, Zwaginga JJ, Roelofs H, Fibbe WE, Oostendorp J, Bajema I, Versteegh MI, Taube C, Hiemstra PS. A phase I study for intravenous autologous mesenchymal stromal cell administration to patients with severe emphysema. QJM. 2016;109:331–6.
Article
CAS
PubMed
PubMed Central
Google Scholar
Weiss DJ, Casaburi R, Flannery R, LeRoux-Williams M, Tashkin DP. A placebocontrolled, randomized trial of mesenchymal stem cells in COPD. Chest. 2013;143:1590–8.
Article
CAS
PubMed
Google Scholar
Simones AA, Beisang DJ, Panoskaltsis-Mortari A, Roberts KD. Mesenchymal stem cells in the pathogenesis and treatment of bronchopulmonary dysplasia: a clinical review. Pediatr Res. 2017. https://doi.org/10.1038/pr.2017.237 (Epub ahead of print), (Epub Sep 25).
PubMed
Google Scholar
Chang YS, Ahn SY, Yoo HS, Sung SI, Choi SJ, Oh WI, Park WS. Mesenchymal stem cells for bronchopulmonary dysplasia: phase 1 dose-escalation clinical trial. J Pediatr. 2014;164:966–72.
Article
PubMed
Google Scholar
Powell SB, Silvestri JM: Safety of intratracheal transplantation of human umbilical cord derived mesenchymal stem cells (HUCB-MSCs) in extremely low birth weight (ELBW) preterm infants at highest risk for bronchopulmonary dysplasia (BPD). Pediatric Academic Societies Meeting, May 6–8, 2017, San Francisco, CA.
Chambers DC, Enever D, Ilic N, Sparks L, Whitelaw K, Ayres J, Yerkovich ST, Khalil D, Atkinson KM, Hopkins PM. A phase 1b study of placenta-derived mesenchymal stromal cells in patients with idiopathic pulmonary fibrosis. Respirology. 2014;19:1013–8.
Article
PubMed
Google Scholar